Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. ...Middle East

PR Newswire - News
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash; transaction represents total equity value of up to $1.5 billion...

Hence then, the article about poseida therapeutics inc announces agreement to be acquired by roche holdings inc was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc. )

Apple Storegoogle play

Last updated :

Also on site :